Published in Hepatology on May 01, 2010
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology (2011) 2.97
Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver. World J Hepatol (2015) 0.95
Perioperative nutritional therapy in liver transplantation. Surg Today (2014) 0.92
The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease. Biomed Res Int (2015) 0.81
The association between the levels of serum ferritin and sex hormones in a large scale of Chinese male population. PLoS One (2013) 0.80
Ferritin and liver allocation? Impact on mortality not only on the waiting list but also after orthotopic liver transplantation should be considered. Hepatology (2010) 0.77
Hepcidin levels in children with chronic liver disease. Saudi J Gastroenterol (2015) 0.75
Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis. PLoS One (2017) 0.75
High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis. Ann Gastroenterol (2016) 0.75
A Point-based Prediction Model for Cardiovascular Risk in Orthotopic Liver Transplantation: The CAR-OLT Score. Hepatology (2017) 0.75
Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet (2003) 4.49
Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int (2011) 3.36
Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transpl (2002) 2.98
Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. Am J Gastroenterol (2010) 2.63
Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology (2006) 2.62
Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. J Hepatol (2012) 2.31
Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2008) 2.30
Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis. Hepatology (2004) 2.17
Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients. J Manag Care Pharm (2008) 2.16
Ammonia levels and the severity of hepatic encephalopathy. Am J Med (2003) 2.14
Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch Intern Med (2006) 2.11
Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology (2002) 1.92
Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology (2004) 1.80
Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg (2005) 1.73
Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology (2005) 1.66
Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video). Gastrointest Endosc (2010) 1.65
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl (2007) 1.58
Treating hepatitis C in the prison population is cost-saving. Hepatology (2008) 1.50
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology (2007) 1.49
Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. Hepatology (2009) 1.47
Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol (2009) 1.42
Kidney transplantation threshold in patients with hepatitis C: a decision analysis model. Transplantation (2015) 1.38
Severe hepatotoxicity due to Hydroxycut: a case report. Dig Dis Sci (2008) 1.38
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol (2008) 1.37
Treatment of hepatitis C. Am J Med (2005) 1.35
Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology (2007) 1.31
Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg (2010) 1.28
Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation. Transplantation (2007) 1.26
Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg (2002) 1.22
A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation. Hepatology (2013) 1.21
Postresection hepatic failure: successful treatment with liver transplantation. Liver Transpl (2007) 1.20
Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcohol Clin Exp Res (2006) 1.17
Viral hepatitis in incarcerated adults: a medical and public health concern. Am J Gastroenterol (2009) 1.17
Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology (2005) 1.17
Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg (2003) 1.15
Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int (2010) 1.14
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Liver Transpl (2004) 1.12
Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults. Nurs Res (2008) 1.11
The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Ann Surg (2013) 1.08
Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways. Liver Transpl (2009) 1.05
Immunization needs of chronic liver disease patients seen in primary care versus specialist settings. Dig Dis Sci (2005) 1.03
Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial. Hepatology (2009) 1.03
Pregnancy and cirrhosis. Liver Transpl (2008) 1.01
Pregnancy and liver transplantation. Liver Int (2008) 1.00
Cardiovascular risk factors following orthotopic liver transplantation: predisposing factors, incidence and management. Liver Int (2010) 1.00
A model to predict the development of mental status changes of unclear cause after liver transplantation. Liver Transpl (2003) 1.00
Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis. Liver Int (2007) 0.98
Effects of a sustained virologic response on outcomes of patients with chronic hepatitis C. Clin Gastroenterol Hepatol (2011) 0.98
Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology (2004) 0.96
Health-related quality of life after liver transplantation for adult recipients. Liver Transpl (2009) 0.96
Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury. Lab Invest (2013) 0.96
Economic burden associated with patients diagnosed with hepatitis C. Clin Ther (2011) 0.95
Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. Arch Surg (2011) 0.95
Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization. Am J Gastroenterol (2002) 0.93
Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis. Dig Dis Sci (2009) 0.93
The effects of hepatitis C recurrence on health-related quality of life in liver transplant recipients. Liver Int (2009) 0.93
GH treatment in adults with chronic liver disease: a randomized, double-blind, placebo-controlled, cross-over study. J Clin Endocrinol Metab (2002) 0.93
Screening for hemochromatosis. Clin Chim Acta (2002) 0.92
Management of Hepatitis C Antiviral Therapy Adverse Effects. Curr Hepat Rep (2010) 0.92
Iron storage disease in Asia-Pacific populations: the importance of non-HFE mutations. J Gastroenterol Hepatol (2013) 0.92
The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis. Liver Int (2012) 0.92
New era of liver transplantation for hepatitis B: a 17-year single-center experience. Ann Surg (2002) 0.91
Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures. Gastrointest Endosc (2009) 0.91
Fulminant liver failure due to usnic acid for weight loss. Am J Gastroenterol (2004) 0.91
Quantitative analysis of the expression of ACAT genes in human tissues by real-time PCR. J Lipid Res (2004) 0.90
Concordance of iron indices in homozygote and heterozygote sibling pairs in hemochromatosis families: implications for family screening. J Hepatol (2002) 0.89
Regional variation in the cost effectiveness of childhood hepatitis A immunization. Pediatr Infect Dis J (2003) 0.89
Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis. Dig Dis Sci (2014) 0.89
Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. J Am Coll Surg (2011) 0.89
Identification and characterization of the hepatic stellate cell transferrin receptor. Am J Pathol (2003) 0.88
Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis. Am J Physiol Gastrointest Liver Physiol (2011) 0.87
Presence and predictors of hepatitis C virus RNA in the semen of homeless men. Biol Res Nurs (2002) 0.87
Complications of cirrhosis. Dis Mon (2008) 0.85
Liver transplantation in the era of model for end-stage liver disease. Liver Int (2004) 0.85
Cirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta-analysis. Liver Int (2014) 0.85
Effect of alcohol on iron storage diseases of the liver. Best Pract Res Clin Gastroenterol (2003) 0.84
The cost effectiveness of hepatitis immunization for US college students. J Am Coll Health (2003) 0.83
Primary prevention of cirrhosis. Public health strategies that can make a difference. Postgrad Med (2004) 0.83
The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation. Surg Today (2003) 0.83
Hepatitis C and lymphoproliferative disorders: from mixed cryoglobulinemia to non-Hodgkin's lymphoma. Clin Gastroenterol Hepatol (2009) 0.82
Management of recurrent hepatocellular carcinoma in liver transplant recipients: a systematic review. Exp Clin Transplant (2012) 0.82
Intravital multiphoton imaging of the selective uptake of water-dispersible quantum dots into sinusoidal liver cells. Small (2014) 0.82
Hyponatremia: clinical associations, prognosis, and treatment in cirrhosis. Exp Clin Transplant (2013) 0.82
Patients with nodular regenerative hyperplasia should be considered for hepatocellular carcinoma screening. Hepatol Res (2013) 0.81
Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues. Liver Transpl (2013) 0.81
A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection. Hepatol Int (2010) 0.81
Deciding liver transplant candidacy: tools of the trade. Liver Int (2008) 0.80
Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Drug Metab Dispos (2011) 0.80
Recurrence of non-viral liver disease after orthotopic liver transplantation. Liver Int (2011) 0.80
Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Ann Surg (2006) 0.80
An economic assessment of pre-vaccination screening for hepatitis A and B. Public Health Rep (2003) 0.80
Capsule endoscopy is not as accurate as esophagogastroduodenoscopy in screening cirrhotic patients for varices. Clin Gastroenterol Hepatol (2011) 0.80
Timing of Hepatitis C Antiviral Therapy in Liver Transplant Recipients With Direct-acting Agents. Exp Clin Transplant (2016) 0.80